Predictive factors of pathological vascular invasion in hepatocellular carcinoma within 3 cm and three nodules without radiological vascular invasion. Issue 10 (4th February 2016)

• Record Type: Journal Article
• Authors: Masuda, Toshiro; Beppu, Toru; Okabe, Hirohisa; Nitta, Hidetoshi; Imai, Katsunori; Hayashi, Hiromitsu; Chikamoto, Akira; Yamamoto, Kenichiro; Ikeshima, Satoshi; Kuramoto, Masafumi; Shimada, Shinya; Baba, Hideo
• Is Part Of: Hepatology research. Volume 46:Issue 10(2016)
• Page Start: 985
• Page End: 991
• Publication Date: 2016-02-04
• Subjects: ablation therapy -- hepatocellular carcinoma -- pathological vascular invasion; Liver -- Diseases -- Periodicals; Liver Diseases -- Periodicals; Foie -- Maladies -- Périodiques; 616.362
• DOI: 10.1111/hepr.12637
• Languages: English
• ISSNs: 1386-6346

Abstract

Abstract : Aim: The aim of this study was to determine the predictive factors of pathological vascular invasion as contra‐indicators for ablation therapy in patients with hepatocellular carcinoma (HCC) within 3 cm and three nodules without radiological vascular invasion. Methods: Two hundred and seventeen patients with HCC within 3 cm and three nodules without radiological vascular invasion who underwent hepatic resection were retrospectively investigated. Results: Pathological vascular invasion was positive in 46 patients, consisting of 38 portal vein invasions, three hepatic vein invasions, two hepatic artery invasions, one hepatic duct invasion and two with portal and hepatic vein invasions. In univariate analysis, patients with α‐fetoprotein (AFP) of more than 100 ng/mL had higher rates of pathological vascular invasion than those without. In addition, patients with protein induced by vitamin K absence (PIVKA‐II) of more than 100 mAU/mL had higher rates of pathological vascular invasion than those without. Multivariate analysis revealed that AFP of more than 100 ng/mL and PIVKA‐II of more than 100 mAU/mL were independent predictive factors for pathological vascular invasion. As these patients were treated with hepatic resection, cumulative 5‐year recurrence‐free and overall survivals were not significantly different between the pathological vascular invasion negative and positive cases. Conclusion: AFP of more than 100 ng/mL and PIVKA‐II of more than 100 mAU/mL can predict pathological vascular invasion in patients with HCC within 3 cm and three nodules without radiological vascular invasion. In treating such cases, hepatic resection rather than local ablation therapy is recommended.